The Clinical Evaluation Timeline Trap: Updates Due Before You Expect

Written by HATEM RABEH, MD, MSc Ing

Your Clinical Evaluation Expert And Partner

in
S

This happens more often than you think.

The regulatory calendar for clinical evaluation is not intuitive. It does not start when you feel something has changed. It does not wait for you to notice a signal. It runs on fixed rules, and those rules apply whether you are monitoring them or not.

The problem is that most manufacturers treat clinical evaluation updates as reactive. Something happens, so they update. A complaint comes in. A new competitor publishes data. A regulation changes. Only then do they think about revising the CER.

But the MDR does not work that way.

The Regulatory Expectation Is Continuous and Proactive

Article 61(11) of the MDR requires manufacturers to update clinical evaluation throughout the lifecycle of the device. That sounds reasonable. But what does “throughout” mean in practice?

It means you do not wait for a trigger. You monitor continuously, and you update at defined intervals, regardless of whether anything obvious has changed.

The manufacturer is expected to have a system that captures new data, assesses relevance, and integrates findings into the CER on a planned schedule. This is not a suggestion. It is a requirement.

When I review files, I see manufacturers who update their CER only when they launch a new variant or prepare for recertification. In between, the document sits untouched. They assume that if no safety signal has emerged, the CER is still valid.

That assumption costs them during audits.

When Are Updates Actually Due?

There is no single answer, and that is part of the trap.

The frequency depends on the device class, the maturity of the technology, the availability of new data, and the findings from PMCF. But there are baseline expectations.

For Class III and implantable devices, updates are typically expected annually. For Class IIb, it may be every one to two years depending on risk. For Class IIa, longer intervals may be acceptable if justified.

But here is the detail that catches people: the clock does not start from the date of certification. It starts from the date of the last CER finalization or update, whichever is most recent.

So if your CER was approved in January 2023, and you have no documented update process, by January 2024 you may already be late for a Class III device.

Even if nothing has changed.

The expectation is not that something must have changed to require an update. The expectation is that you have checked whether something has changed, documented your review, and confirmed that the conclusions remain valid.

What Triggers an Unscheduled Update?

Beyond the periodic schedule, there are also event-based triggers that require an immediate update.

A serious incident involving your device. A field safety corrective action. New data from PMCF that changes the risk-benefit assessment. A significant publication in your literature review that contradicts your SOTA.

These are not optional updates. They are mandatory.

The challenge is that manufacturers often do not recognize these triggers in real time. They see an incident, but they categorize it as a one-off. They see a new publication, but they assume it is not relevant because it involves a slightly different population.

By the time the auditor reviews the file, months have passed. The CER is now outdated, and the manufacturer has no documented justification for why the update was delayed.

The auditor does not accept retroactive reasoning. They want to see that the trigger was identified at the time, assessed, and acted upon within a reasonable period.

Why Manufacturers Miss the Deadlines

There are three common reasons.

First, they do not track the update schedule explicitly. The CER sits in the technical file, but there is no calendar entry, no SOP trigger, no responsibility assigned. It becomes invisible until someone asks for it.

Second, they confuse “no change” with “no update needed.” They think that if the device is stable and the market is quiet, the CER is still valid. But regulatory compliance is not about whether the device has changed. It is about whether you have reviewed the evidence landscape.

Third, they underestimate the effort required. Updating a CER is not a quick task. It requires literature review, PMCF data integration, SOTA reassessment, and possibly consultation with clinical experts. If you wait until the deadline, you do not have time to do it properly.

So the update gets rushed, or it gets delayed, and either way the file suffers.

How to Avoid the Trap

The solution is not complex, but it requires discipline.

First, define your update schedule explicitly in your clinical evaluation plan. State the frequency for periodic updates based on device class and risk. State the criteria for event-triggered updates. Assign responsibility.

Second, integrate the update schedule into your quality management system. Create calendar reminders. Include CER updates in your annual regulatory calendar. Treat them as mandatory milestones, not optional tasks.

Third, maintain a rolling evidence review process. Do not wait until the update is due to start reviewing literature. Conduct literature reviews quarterly or biannually, depending on your device. Keep a log of publications reviewed and their relevance assessment.

When the update is due, you already have most of the evidence reviewed. The update becomes a summary and reassessment, not a scramble to catch up.

Fourth, document everything. Even if you conclude that no update to the CER content is needed, document the review process. Show what you checked, what you found, and why you concluded the existing CER remains valid.

That documentation is what the auditor needs to see.

What Happens If You Miss the Deadline

The consequences depend on the timing and the auditor.

If you are a few months late but you can show a documented review process and a plan to finalize the update, the auditor may issue an observation or a minor nonconformity.

If you are a year or more overdue, or if you have no evidence of any review activity, expect a major nonconformity. The auditor will question whether your clinical evaluation system is functioning at all.

In the worst case, if the delay coincides with a safety issue or a change in SOTA that you failed to capture, the Notified Body may suspend your certificate until the CER is brought up to date.

I have seen this happen. It is avoidable.

A Final Note on PMCF Integration

One of the most overlooked aspects of the update timeline is the integration of PMCF data.

Your PMCF plan specifies when data will be collected and analyzed. That analysis must feed into the CER. If your PMCF report is finalized in March, your CER should be updated shortly after to integrate those findings.

This is not automatic. It requires coordination between clinical affairs, regulatory, and quality. But if the PMCF data contradicts or refines your CER conclusions, and you do not update the CER, you are now out of compliance with both the PMCF requirements and the clinical evaluation requirements.

The timeline trap is often sprung here, because manufacturers treat PMCF and CER updates as separate processes. They are not. They are interdependent, and the timelines must align.

Closing Thought

The clinical evaluation timeline is not flexible. It is defined by regulation, by device risk, and by the evidence landscape. It runs whether you are watching it or not.

The manufacturers who avoid the trap are the ones who treat clinical evaluation as a continuous process, not a periodic task. They monitor, they document, they update on schedule, and they integrate PMCF findings as they emerge.

The ones who fall into the trap are the ones who assume that silence means compliance.

It does not.

Your CER is only as current as your last documented review. If you cannot show when that review happened and what it covered, you do not have a compliant clinical evaluation system.

Even if your device is safe. Even if your data is strong. The system must be visible, documented, and on schedule.

That is what the auditor will check. That is what you need to deliver.

Peace,
Hatem
Clinical Evaluation Expert for Medical Devices
Follow me for more insights and practical advice.